Physician profile
Eric John Chapman
NPI 1003136839
$2,022.29
in general payments reported to CMS, 2019-2025
12 companies · $694 in 2025
The $694 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.82 · 2020: $84.06 · 2021: $140 · 2022: $135 · 2023: $430 · 2024: $504 · 2025: $694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,213 · Travel and Lodging: $380 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,212.68 |
| Travel and Lodging | $379.87 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $950.29 | 2021-2025 | Interstim, Altaviva |
| Boston Scientific Corporation | $566.65 | 2019-2025 | Rezum Generator, Spaceoar Vue System - 10ml, Ams 700 |
| Laborie Medical Technologies Corp. | $128.61 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Teleflex LLC | $126.58 | 2021-2022 | |
| Medtronic USA, INC. | $61.26 | 2020 | |
| Coloplast Corp | $51.38 | 2023 | Porges Coloplast |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Progenics Pharmaceuticals, INC. | $31.94 | 2022-2024 | |
| Neotract INC. | $22.80 | 2020 | |
| Axonics, INC. | $18.01 | 2023 | Axonics |
| Tolmar, INC. | $14.89 | 2025 | Eligard, Jatenzo |
| Abbvie INC. | $14.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Chapman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.